Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymyositis: an overdiagnosed entity.

M F G van der Meulen1, I M Bronner, J E Hoogendijk

  • 1Rudolf Magnus Institute of Neuroscience, Department of Neurology, University Medical Center, Utrecht, The Netherlands. M.F.G.vdMeulen@neuro.azu.nl

Neurology
|August 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness of a smartphone-based personalized lifestyle intervention for symptoms of depression in primary care: protocol for a cluster-randomized controlled trial (LIDIAS).

Trials·2026
Same author

Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.

The Journal of dermatology·2025
Same author

Differential expression pattern of Bcl-2 family members in B and T cells in systemic lupus erythematosus and rheumatoid arthritis.

Arthritis research & therapy·2023
Same author

Vascularized Bone Grafts from the Lateral Femoral Condyle for the Treatment of Avascular Lunate Necrosis (Kienböck's).

Indian journal of orthopaedics·2023
Same author

Development of a simple standardized scoring system for assessing large vessel vasculitis by 18F-FDG PET-CT and differentiation from atherosclerosis.

European journal of nuclear medicine and molecular imaging·2023
Same author

In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort study.

Seminars in arthritis and rheumatism·2022
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Polymyositis (PM) is often overdiagnosed. Many autoimmune myositis patients cannot be specifically diagnosed, and some cases initially diagnosed as unspecified myositis later develop connective tissue disease (CTD).

Area of Science:

  • Neurology
  • Rheumatology
  • Immunology

Background:

  • Differentiating inflammatory myopathies like polymyositis (PM) and dermatomyositis (DM) is challenging.
  • Established criteria rely on skin changes and histopathology, but applicability varies.

Purpose of the Study:

  • To investigate the diagnostic accuracy of features for PM and DM.
  • To evaluate the long-term outcomes of patients with initially unspecified myositis.

Main Methods:

  • Retrospective follow-up study of 165 patients diagnosed with myositis.
  • Inclusion criteria: subacute onset, symmetric proximal weakness, and exclusion of other neuromuscular disorders.
  • Evaluations included clinical, laboratory, and histopathologic assessments between 1977 and 1998.

Related Experiment Videos

Main Results:

  • At initial evaluation, diagnoses included PM (5%), DM (36%), unspecified myositis (39%), and possible myositis (19%).
  • Five of nine PM patients later exhibited features of sporadic inclusion body myositis (s-IBM).
  • Ten of 38 patients with unspecified myositis developed connective tissue disease (CTD) upon follow-up.

Conclusions:

  • Polymyositis is frequently overdiagnosed, with many cases misclassified.
  • A significant portion of autoimmune myositis patients lack specific PM or DM diagnoses.
  • Unspecified myositis carries a risk of subsequent CTD development.